Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/28/2836806/0/en/Editas-Medicine-Announces-Fourth-Quarter-and-Full-Year-2023-Results-and-Business-Updates.html
https://www.globenewswire.com//news-release/2024/02/21/2832602/0/en/Editas-Medicine-Announces-Fourth-Quarter-and-Full-Year-2023-Results-Conference-Call-and-Upcoming-Investor-Events.html
https://www.globenewswire.com/news-release/2024/01/31/2821218/0/en/Editas-Medicine-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/08/2805430/0/en/Editas-Medicine-Highlights-2024-Anticipated-Milestones-and-Strategic-Priorities-at-the-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/01/03/2803160/0/en/Editas-Medicine-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.fiercebiotech.com/biotech/after-long-standing-patent-battle-vertex-pays-100m-license-editas-gene-editing-tech
https://www.fiercebiotech.com/biotech/ash-after-landmark-fda-approvals-editas-still-thinks-its-gene-therapy-differentiates-itself
https://www.globenewswire.com//news-release/2023/12/11/2794110/0/en/Editas-Medicine-Announces-New-EDIT-301-Safety-and-Efficacy-Data-in-17-Patients-Presented-Today-at-the-American-Society-of-Hematology-ASH-Annual-Meeting-and-in-a-Company-sponsored-W.html
https://www.globenewswire.com//news-release/2023/11/03/2773078/0/en/Editas-Medicine-Announces-Third-Quarter-2023-Results-and-Business-Updates.html
https://www.globenewswire.com//news-release/2023/11/02/2772452/0/en/Editas-Medicine-to-Present-Clinical-Data-from-the-RUBY-and-EdiTHAL-Trials-of-EDIT-301-at-the-ASH-2023-Annual-Meeting-and-in-a-Company-sponsored-Webinar.html